...
首页> 外文期刊>Journal of clinical laboratory analysis. >Correlation of microRNA‐125a/b with acute respiratory distress syndrome risk and prognosis in sepsis patients
【24h】

Correlation of microRNA‐125a/b with acute respiratory distress syndrome risk and prognosis in sepsis patients

机译:MicroRNA-125A / B与急性呼吸窘迫综合征风险和预后在脓毒症患者的相关性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective This study was conducted to explore the association of microRNA (miR)‐125a and miR‐125b with acute respiratory distress syndrome (ARDS) risk and to investigate their correlation with clinical characteristics and prognosis in sepsis patients. Methods Totally 150 sepsis patients admitted to our hospital were consecutively enrolled and another 150 healthy subjects were enrolled as healthy controls (HCs). Their blood samples were collected for miR‐125a and miR‐125b detection by real‐time quantitative polymerase chain reaction. Besides, ARDS occurrence and 28‐day mortality were documented in all sepsis patients. Results MiR‐125a and miR‐125b relative expressions were increased in ARDS‐sepsis patients/non‐ARDS‐sepsis patients compared with HCs, while only miR‐125b but not miR‐125a was elevated in ARDS‐sepsis patients compared with non‐ARDS‐sepsis patients. Receiver operating characteristic (ROC) curve presented that miR‐125a (AUC: 0.650, 95%CI: 0.549‐0.750) and miR‐125b (AUC: 0.739, 95%CI: 0.653‐0.823) could differentiate ARDS‐sepsis patients from non‐ARDS‐sepsis patients, and miR‐125b was of increased predictive value compared with miR‐125a numerically. In sepsis patients, miR‐125a relative expression was positively associated with serum creatinine (Scr), chronic health evaluation (APACHE) II score, sequential organ failure assessment (SOFA) score, and miR‐125b was positively associated with Scr, C‐reactive protein (CRP), APACHE II score, SOFA score, and chronic obstructive pulmonary disease. All sepsis patients were categorized into survivors and deaths according to 28‐day mortality, and miR‐125b but not miR‐125a was upregulated in deaths compared with survivors. Conclusion Both of miR‐125a and miR‐125b predict ARDS risk, while only miR‐125b is of value in prognosis prediction in sepsis patients.
机译:目的进行该研究以探讨MicroRNA(MIR)-125A和MIR-125B与急性呼吸窘迫综合征(ARDS)风险的关联,并研究其与败血症患者临床特征和预后的相关性。方法完全150例患有院患者的脓毒症患者均为连续注册,另外150名健康受试者纳入健康控制(HCS)。通过实时定量聚合酶链反应收集其血液样品,用于MiR-125a和miR-125b检测。此外,在所有败血症患者中记录了ARDS发生和28天的死亡率。结果,与HCS相比,ARDS-epsis患者/非ARADS-SEPSIS患者中的MIR-125A和MIR-125B相对表达增加,而在ARDS-SEPSIS患者中仅升高MIR-125B但不是miR-125a,而不是非ARDS - 患者。接收器操作特征(ROC)曲线呈现miR-125a(AUC:0.650,95%CI:0.549-0.750)和miR-125b(AUC:0.739,95%CI:0.653-0.823)可以将ARDS-Sepsis患者与非-Ards-epsis患者,与数值相比,miR-125b的预测值增加了预测值。在败血症患者中,miR-125a相对表达与血清肌酐(scr),慢性健康评估(apache)II评分,顺序器官衰竭评估(沙发)评分呈正相关,MiR-125b与SCR,C反应呈正相关蛋白质(CRP),Apache II得分,沙发评分和慢性阻塞性肺病。根据28天的死亡率,所有脓毒症患者均分为幸存者和死亡,而miR-125b,但没有miR-125a与幸存者相比,死亡中未降低miR-125a。结论MIR-125A和MIR-125B两者预测ARDS风险,而MIR-125B在败血症患者的预后预测中具有价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号